AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionMeridian Wealth Management, LLC
Latest Disclosed Ownership76,404 shares
Latest Disclosed Value $ 16,617,150
Meridian Wealth Management, LLC reports 1.60% increase in ownership of ABBV / AbbVie Inc.

On May 6, 2026 - Meridian Wealth Management, LLC filed a 13F-HR form disclosing ownership of 76,404 shares of AbbVie Inc. (US:ABBV) valued at $16,617,106 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 75,198 shares of AbbVie Inc.. This represents a change in shares of 1.60% during the quarter. The current value of the position is $16,589,601 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F ABBVIE COM 00287Y109 76,404 1,206 1.60 16,617 -3.29 0.5729
2026-02-04 2025-12-31 13F ABBVIE COM 00287Y109 75,198 -450 -0.59 17,182 -1.90 0.6048
2025-11-04 2025-09-30 13F ABBVIE COM 00287Y109 75,648 -1,118 -1.46 17,516 22.92 0.6713
2025-08-08 2025-06-30 13F ABBVIE COM 00287Y109 76,766 -1,053 -1.35 14,249 -12.60 0.6084
2025-05-12 2025-03-31 13F ABBVIE COM 00287Y109 77,819 5,530 7.65 16,305 26.93 0.7893
2025-02-06 2024-12-31 13F ABBVIE COM 00287Y109 72,289 -2,589 -3.46 12,846 -13.13 0.6077
2024-11-12 2024-09-30 13F ABBVIE COM 00287Y109 74,878 2,363 3.26 14,787 18.89 0.7268
2024-08-08 2024-06-30 13F ABBVIE COM 00287Y109 72,515 72,515 12,438 1.4867
2024-04-25 2024-03-31 13F ABBVIE COM 00287Y109 0 -71,481 -100.00 0 -100.00
2024-02-08 2023-12-31 13F ABBVIE COM 00287Y109 71,481 24,996 53.77 11,077 59.86 0.7073
2023-10-17 2023-09-30 13F ABBVIE COM 00287Y109 46,485 3,439 7.99 6,929 19.49 0.4245
2023-08-02 2023-06-30 13F ABBVIE COM 00287Y109 43,046 -51 -0.12 5,800 -15.56 0.4889
2023-05-15 2023-03-31 13F ABBVIE COM 00287Y109 43,097 5,041 13.25 6,868 11.67 0.5990
2023-02-14 2022-12-31 13F ABBVIE COM 00287Y109 38,056 -1,072 -2.74 6,150 17.12 0.6022
2022-11-14 2022-09-30 13F ABBVIE COM 00287Y109 39,128 -1,806 -4.41 5,251 -16.25 0.5649
2022-08-05 2022-06-30 13F ABBVIE COM 00287Y109 40,934 -3,214 -7.28 6,270 -12.39 0.5129
2022-05-12 2022-03-31 13F ABBVIE COM 00287Y109 44,148 -2,723 -5.81 7,157 12.78 0.7822
2022-01-27 2021-12-31 13F ABBVIE COM 00287Y109 46,871 2,069 4.62 6,346 31.31 0.6776
2021-10-15 2021-09-30 13F ABBVIE COM 00287Y109 44,802 4,751 11.86 4,833 7.14 0.5961
2021-07-22 2021-06-30 13F ABBVIE COM 00287Y109 40,051 5,099 14.59 4,511 19.28 0.5749
2021-05-07 2021-03-31 13F ABBVIE COM 00287Y109 34,952 -5,377 -13.33 3,782 -12.47 0.5505
2021-01-19 2020-12-31 13F ABBVIE COM 00287Y109 40,329 2,635 6.99 4,321 30.90 0.6857
2020-10-09 2020-09-30 13F ABBVIE COM 00287Y109 37,694 11,699 45.00 3,301 29.35 0.8093
2020-07-15 2020-06-30 13F ABBVIE COM 00287Y109 25,995 586 2.31 2,552 31.89 0.8542
2020-04-16 2020-03-31 13F ABBVIE COM 00287Y109 25,409 21,406 534.75 1,935 446.61 0.8572
2020-01-09 2019-12-31 13F ABBVIE COM 00287Y109 4,003 169 4.41 354 22.07 0.1702
2019-11-08 2019-09-30 13F ABBVIE COM 00287Y109 3,834 596 18.41 290 -87.69 0.1365
2019-07-19 2019-06-30 13F ABBVIE COM 00287Y109 3,238 68 2.15 2,355 823.53 0.0953
2019-06-03 2019-03-31 13F/A-1 ABBVIE COM 00287Y109 3,170 221 7.49 255 -6.25 0.1160
2019-05-15 2019-03-31 13F ABBVIE COM 00287Y109 3,170 221 2,555
2019-02-05 2018-12-31 13F ABBVIE COM 00287Y109 2,949 805 37.55 272 33.99 0.1602
2018-10-19 2018-09-30 13F ABBVIE COM 00287Y109 2,144 -3,663 -63.08 203 -62.27 0.0873
2018-08-06 2018-06-30 13F ABBVIE COM 00287Y109 5,807 3,273 129.16 538 124.17 0.2532
2018-05-08 2018-03-31 13F ABBVIE COM 00287Y109 2,534 -354 -12.26 240 -13.98 0.1197
2018-01-30 2017-12-31 13F ABBVIE COM 00287Y109 2,888 35 1.23 279 8.56 0.1719
2017-10-31 2017-09-30 13F ABBVIE COM 00287Y109 2,853 -4,391 -60.62 257 -51.05 0.1629
2017-07-25 2017-06-30 13F ABBVIE COM 00287Y109 7,244 4,114 131.44 525 157.35 0.3326
2017-05-17 2017-03-31 13F/A-1 ABBVIE COM 00287Y109 3,130 3,130 204 0.1223
2017-05-15 2017-03-31 13F ABBVIE INC COM Common 00287Y109 203,956 204
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.